pantoprazole has been researched along with Cancer of ILEUM in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corsello, A | 1 |
| Di Filippo, L | 1 |
| Massironi, S | 1 |
| Sileo, F | 1 |
| Dolcetta Capuzzo, A | 1 |
| Gemma, M | 1 |
| Carlucci, C | 1 |
| Cusini, C | 1 |
| Colombo, B | 1 |
| Dallatomasina, A | 1 |
| Franchi, GM | 1 |
| Corti, A | 1 |
| Manzoni, MF | 1 |
1 other study available for pantoprazole and Cancer of ILEUM
| Article | Year |
|---|---|
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Antineoplastic Agents; Area Under Curve; Biomarkers, | 2018 |